The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review.Published in:Lupus, 2018, v. 27, n. 13, p. 2135, doi. 10.1177/0961203318804879By:Peterknecht, E.;Keasey, M. P.;Beresford, M. W.Publication type:Article
Hsp40 Molecules That Target to the Ubiquitin-proteasome System Decrease Inclusion Formation in Models of Polyglutamine Disease.Published in:Molecular Therapy, 2007, v. 15, n. 6, p. 1100, doi. 10.1038/sj.mt.6300163By:Howarth, J. L.;Kelly, S.;Keasey, M. P.;Glover, C. P. J.;Lee, Y.-B.;Mitrophanous, K.;Chapple, J. P.;Gallo, J. M.;Cheetham, M. E.;Uney, J. B.Publication type:Article
Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1.Published in:Scientific Reports, 2016, p. 25802, doi. 10.1038/srep25802By:Keasey, M. P.;Lemos, R. R.;Hagg, T.;Oliveira, J. R. M.Publication type:Article